A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Naloxone Hydroxylamine - Request Quote

Picture of Naloxone Hydroxylamine

Naloxone Hydroxylamine

SZ CAT No:SZ-N064013
CAS No
NA
Mol.F.
C19H21NO5
Mol.Wt.
343.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Naloxone Hydroxylamine is chemically (4R,4aS,7aR,12bS)-4a-(allyloxy)-3,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one. Naloxone Hydroxylamine is supplied with detailed characterization data compliant with regulatory guideline. Naloxone Hydroxylamine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naloxon.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Naloxone Hydroxylamine

Purchase Naloxone Hydroxylamine

Naloxone Hydroxylamine suppliers

Naloxone Hydroxylamine manufacturers

Naloxone Hydroxylamine price

Order Naloxone Hydroxylamine

Enquire Naloxone Hydroxylamine

Naloxone Hydroxylamine cost

Naloxone Hydroxylamine Supplier

Naloxone Hydroxylamine Distributor

Naloxone Hydroxylamine for Method Validation

Naloxon Reference Standard

Naloxone Hydroxylamine for ANDA Filing

Naloxone Hydroxylamine for Forced Degradation Studies

Naloxone Hydroxylamine Identification Standards

Naloxone Hydroxylamine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,